Literature DB >> 8910983

Epidemiologic characteristics of conotruncal heart defects in California, 1987-1988.

C D O'Malley1, G M Shaw, C R Wasserman, E J Lammer.   

Abstract

In this population-based case-control study, we explored the association of selected parental and infant characteristics from the birth certificates of children with conotruncal heart defects. We compared 252 cases to a random sample of 5,000 nonmalformed infants from a cohort of 341,839 California live births for 1987-1988. The prevalence of conotruncal defects was 0.732 per 1,000 total births. A decreased risk (OR = 0.55, 95% CI0.33-0.89) for delivering infants with conotruncal defects was found among mothers born in Mexico compared to mothers born in California. An increased risk was observed for Native American mothers compared to non-Hispanic whites (OR = 2.6, 95% CI 1.1-6.0). We also compared risks associated with the individual diagnoses that comprise the group of conotruncal defects. Only minor differences in risk estimates between the anatomic diagnoses were observed, lending support to the methodologic approach of using conotruncal defects as a single category of heart defects in etiologic investigations.

Entities:  

Mesh:

Year:  1996        PMID: 8910983     DOI: 10.1002/(SICI)1096-9926(199606)53:6<374::AID-TERA8>3.0.CO;2-#

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  9 in total

Review 1.  Getting to the heart of the matter: epidemiology of cyanotic heart defects.

Authors:  Jennifer L Kornosky; Hamisu M Salihu
Journal:  Pediatr Cardiol       Date:  2008-01-10       Impact factor: 1.655

2.  Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects.

Authors:  Kazutoyo Osoegawa; David M Iovannisci; Bin Lin; Christina Parodi; Kathleen Schultz; Gary M Shaw; Edward J Lammer
Journal:  Am J Med Genet A       Date:  2013-10-11       Impact factor: 2.802

3.  Identification of ZFPM2 mutations in sporadic conotruncal heart defect patients.

Authors:  Tian Pu; Yang Liu; Rang Xu; Fen Li; Sun Chen; Kun Sun
Journal:  Mol Genet Genomics       Date:  2017-10-10       Impact factor: 3.291

4.  Cytogenomic Evaluation of Subjects with Syndromic and Nonsyndromic Conotruncal Heart Defects.

Authors:  Karen Regina de Souza; Rafaella Mergener; Janaina Huber; Lucia Campos Pellanda; Mariluce Riegel
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

5.  Novel missense variants of ZFPM2/FOG2 identified in conotruncal heart defect patients do not impair interaction with GATA4.

Authors:  Wenwen Zhang; Li Shen; Zhantao Deng; Yibing Ding; Xuming Mo; Zhengfeng Xu; Qian Gao; Long Yi
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

6.  Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects.

Authors:  Shuang Zhou; Qingjie Wang; Zhuo Meng; Jiayu Peng; Yue Zhou; Wenting Song; Jian Wang; Sun Chen; Kun Sun
Journal:  J Transl Med       Date:  2020-07-14       Impact factor: 5.531

7.  Novel mutations of the SRF gene in Chinese sporadic conotruncal heart defect patients.

Authors:  Xu Mengmeng; Xu Yuejuan; Chen Sun; Lu Yanan; Li Fen; Sun Kun
Journal:  BMC Med Genet       Date:  2020-05-07       Impact factor: 2.103

8.  Haploinsufficiency of insulin gene enhancer protein 1 (ISL1) is associated with d-transposition of the great arteries.

Authors:  Kazutoyo Osoegawa; Kathleen Schultz; Kenneth Yun; Nebil Mohammed; Gary M Shaw; Edward J Lammer
Journal:  Mol Genet Genomic Med       Date:  2014-04-17       Impact factor: 2.183

9.  A loss-of-function mutation p.T52S in RIPPLY3 is a potential predisposing genetic risk factor for Chinese Han conotruncal heart defect patients without the 22q11.2 deletion/duplication.

Authors:  Nanchao Hong; Erge Zhang; Qingjie Wang; Xiaoqing Zhang; Fen Li; Qihua Fu; Rang Xu; Yu Yu; Sun Chen; Yuejuan Xu; Kun Sun
Journal:  J Transl Med       Date:  2018-09-21       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.